Pin It on Pinterest

FR
EN
Toulouse Cancer Research Center
Toulouse Cancer Research Center
Toulouse Cancer Research Center
FR
EN
FR
EN
The PI3K alpha inhibition sensitizes ovarian cancer with PIK3CA mutation to conventional chemotherapy
Role of Vps34, presentation at the 2nd Young Scientist Cancer Congress
Exploring biological characteristics  of lung cancer in each patient gives clues on differences in the way the patient’s immune system fights against the tumour
Fascination with new therapeutic approaches
Pink October: Breast cancer awareness month
On the occasion of the World Cancer Day, digital round table “Toulouse: innovation in oncology (in french)
1st meeting of the FBI France-BioImaging Mechanobiology – Workshop @CRCT by SigDyn Team
The SigDyn team receives Obtention two major grants
Dr. Marc Poirot new member of the Editorial Board of the JBC
Centre de Recherches en Cancérologie de Toulouse
Centre de Recherches en Cancérologie de Toulouse